Neuroone Medical Technologies (NMTC) Short-Term Debt issuances (2016 - 2017)

Neuroone Medical Technologies (NMTC) reported Short-Term Debt issuances of $328429.0 for Q4 2017, down 7.32% on a YoY basis from $354360.0 in Q4 2016, and down 7.32% quarter-over-quarter from $354360.0 in Q4 2016.

Neuroone Medical Technologies (NMTC) Short-Term Debt issuances (2016 - 2017) Analysis & Trends

Neuroone Medical Technologies has reported Short-Term Debt issuances for 2 years, with the latest figure at $328429.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 31.00 Mn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn -
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn -
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn -
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn -
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn -1.00 Mn
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 12.88 Mn
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn 37.80 Mn
10 Neuroone Medical Technologies 29.19 Mn 26.38 Mn 1.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 328,429.00
Dec 31, 2017 328,429.00
Dec 31, 2016 354,360.00
Dec 31, 2016 354,360.00